Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 4/20 | 0.47 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | BCHE | P06276 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | PYGL | P06737 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6944939 | 1.00 | BACE1 (0.47) | BACE1SLC6A11ALDH1A1HTTNCOA1 | |
| SCHEMBL6944942 | 1.00 | BACE1 (0.47) | BACE1SLC6A11ALDH1A1HTTNCOA1 | |
| SCHEMBL6944317 | 1.00 | BACE1 (0.47) | BACE1SLC6A11ALDH1A1HTTNCOA1 | |
| SCHEMBL10707926 | 1.00 | BACE1 (0.47) | BACE1SLC6A11ALDH1A1HTTNCOA1 | |
| SCHEMBL2712694 | 1.00 | BACE1 (0.47) | BACE1SLC6A11ALDH1A1HTTNCOA1 | |
| SCHEMBL9012913 | 0.88 | BACE1 (0.50) | BACE1SLC6A11NPC1RAB9ABCHE | |
| SCHEMBL13536302 | 0.87 | BACE1 (0.45) | BACE1SLC6A11ALDH1A1HTTNCOA1 | |
| SCHEMBL13567455 | 0.87 | BACE1 (0.45) | BACE1SLC6A11ALDH1A1HTTNCOA1 | |
| SCHEMBL14865952 | 0.87 | CTRB1 (0.53) | NPC1RAB9ABCHE | |
| SCHEMBL6501344 | 0.86 | CTRB1 (0.54) | BACE1NPC1RAB9APYGL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3409765-B1 | KETOREDUCTASE-MEDIATED STEREOSELECTIVE ROUTE TO ALPHA CHLOROALCOHOLS | CODEXIS INC (US) | 2021-08-04 | — | — | EP | claimed |
| EP-3409765-A2 | KETOREDUCTASE-MEDIATED STEREOSELECTIVE ROUTE TO ALPHA CHLOROALCOHOLS | Codexis, Inc. (US) | 2018-12-05 | — | — | EP | claimed |
| EP-2446025-B1 | KETOREDUCTASE-MEDIATED STEREOSELECTIVE ROUTE TO ALPHA CHLOROALCOHOLS | CODEXIS INC (US) | 2018-08-08 | — | — | EP | claimed |
| US-9404092-B2 | Ketoreductase-mediated stereoselective route to alpha chloroalcohols | CODEXIS, INC. (US) | 2016-08-02 | — | — | US | claimed |
| US-20160160187-A1 | KETOREDUCTASE-MEDIATED STEREOSELECTIVE ROUTE TO ALPHA CHLOROALCOHOLS | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2016-06-09 | — | — | US | claimed |
| US-8796002-B2 | Polypeptides for a ketoreductase-mediated stereoselective route to alpha chloroalcohols | CODEXIS, INC. (US) | 2014-08-05 | — | — | US | claimed |
| US-20120190086-A1 | KETOREDUCTASE-MEDIATED STEREOSELECTIVE ROUTE TO ALPHA CHLOROALCOHOLS | CODEXIS, INC. (US) | 2012-07-26 | — | — | US | claimed |
| EP-3409765-B1 | KETOREDUCTASE-MEDIATED STEREOSELECTIVE ROUTE TO ALPHA CHLOROALCOHOLS | CODEXIS INC (US) | 2021-08-04 | — | — | EP | disclosed |
| EP-3409765-A2 | KETOREDUCTASE-MEDIATED STEREOSELECTIVE ROUTE TO ALPHA CHLOROALCOHOLS | Codexis, Inc. (US) | 2018-12-05 | — | — | EP | disclosed |
| EP-2446025-B1 | KETOREDUCTASE-MEDIATED STEREOSELECTIVE ROUTE TO ALPHA CHLOROALCOHOLS | CODEXIS INC (US) | 2018-08-08 | — | — | EP | disclosed |
| US-9404092-B2 | Ketoreductase-mediated stereoselective route to alpha chloroalcohols | CODEXIS, INC. (US) | 2016-08-02 | — | — | US | disclosed |
| US-20160160187-A1 | KETOREDUCTASE-MEDIATED STEREOSELECTIVE ROUTE TO ALPHA CHLOROALCOHOLS | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2016-06-09 | — | — | US | disclosed |
| US-8796002-B2 | Polypeptides for a ketoreductase-mediated stereoselective route to alpha chloroalcohols | CODEXIS, INC. (US) | 2014-08-05 | — | — | US | disclosed |
| WO-2013014633-A1 | PROCESS FOR PREPARATION OF ATAZANAVIR OR ITS BISULFATE SALT | RANBAXY LABORATORIES LIMITED (IN) | 2013-01-31 | — | — | WO | disclosed |
| US-20120190086-A1 | KETOREDUCTASE-MEDIATED STEREOSELECTIVE ROUTE TO ALPHA CHLOROALCOHOLS | CODEXIS, INC. (US) | 2012-07-26 | — | — | US | disclosed |
| EP-2446025-A2 | KETOREDUCTASE-MEDIATED STEREOSELECTIVE ROUTE TO ALPHA CHLOROALCOHOLS | Codexis, Inc. (US) | 2012-05-02 | — | — | EP | disclosed |